Speaker Profile
M.D., Chief, Division of Neuroimmunology and Glial Biology, UCSF
Biography
Dr. Ari J. Green is Chief of the Division of Neuroimmunology and Glial Biology in the Department of Neurology at the University of California, San Francisco, where he leads more than 20 laboratories and groups dedicated to understanding and treating multiple sclerosis (MS) and related disorders. He also serves as Medical Director of the UCSF MS and Neuroinflammation Center, one of the largest clinics of its kind in the United States. Dr. Green’s research focuses on developing and validating biomarkers to measure remyelination, repair, and disease progression, with the goal of accelerating clinical trials for reparative therapies. His scientific contributions include leading the first successful Phase II clinical trial of a remyelinating agent for MS and developing methods to monitor myelin repair. He also co-directs the Program in Remyelination and Repair with Dr. Jonah Chan and the Neurodiagnostics Center in the Department of Neurology.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
David Liebeskind, UCLA
PMWC Award Ceremony
• Li-Huei Tsai, MIT Picower Institute (Pioneer)
• Thomas C. Südhof, Stanford (Nobel Laureate, Pioneer)
• David Holtzman, WashU (Pioneer)
• Henrik Zetterberg, UCL / Gothenburg (Luminary)
Featured Speakers
• Thomas C. Südhof, Stanford
• Li-Huei Tsai, MIT Picower Institute
• David Holtzman, WashU
• Henrik Zetterberg, UCL / Gothenburg
• Mark Mintun, Lilly
• Randall Bateman, WashU
• Nikolaos Mellios, Circular Genomics
• Robert Rissman, USC
• Lynn Kramer, Eisai
• Thomas F. Tropea, University of Pennsylvania
• Ari J. Green, UCSF
• Diane Chan, Mass General Brigham
• Leslie Shaw, University of Pennsylvania
• Prashanthi Vemuri, Mayo Clinic
• Kejal Kantarci, Mayo Clinic
• Dan Huddleston, Lightbox Science
• Patrick Brannelly, 10K Brains
• Allan Levey, Emory
From Blood Test to Treatment
Are we finally diagnosing Alzheimer's early enough to change care?
Precision Diagnostics Across Neurology
From biomarker to bedside across neurological disease.
Neurodegeneration Beyond Alzheimer's
Parkinson's, ALS, and FTD in the precision era.
AI & Imaging Across Neurological Disease
Precision phenotyping in stroke, epilepsy, and neurodegeneration.
Why Precision Neurology Is Not Scaling
The evidence, infrastructure, access, and workflow barriers that must be fixed.
Harnessing Brain Rhythms
Gamma oscillations, brain circuits, and the future of neurotherapy.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
